锡兰绿茶中黄酮类成分对缺氧人脑上皮细胞的治疗作用

锡兰绿茶中黄酮类成分对缺氧人脑上皮细胞的治疗作用

黄山红, Ranil De Silva^*

Department of Anatomy, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka

收稿日期:2008-09-30 修回日期:2008-12-05 出版日期:2008-12-15 发布日期:2008-12-15
通讯作者: Ranil De Silva*

Therapeutic effects of flavonoids from Ceylon green tea on hypoxic human brain epithelial cells

Shan-Hong Huang, Ranil De Silva^*

Department of Anatomy, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka

Received:2008-09-30 Revised:2008-12-05 Online:2008-12-15 Published:2008-12-15
Contact: Ranil De Silva*

摘要/Abstract

摘要：

为研究从锡兰绿茶(Dilmah)中提取纯化的黄酮类有效成分对缺氧人脑上皮细胞的治疗作用, 体外培养人脑上皮细胞(HBEC), 给与锡兰绿茶黄酮提取物治疗后造缺氧模型, 检测锡兰绿茶中的黄酮类化合物的抗氧化活性及脑细胞的生存情况, 探究其对缺氧脑细胞氧化应激的影响。生化检测显示锡兰绿茶提取物的自由基的清除抑制率(ABTS)为68% ± 2.8%, 次氯酸漂白邻苯三酚红抑制率为79% ± 4.5%。缺氧后, 空白对照组细胞生存率为29% ± 2.3%, 而锡兰绿茶黄酮提取物治疗组为41% ± 4.7%, 氯沙坦治疗组为39% ± 3.1%。同时, 黄铜提取物与氯沙坦治疗组LDH 释放分别减少75% ± 3.7% 和79% ± 3.5%。锡兰绿茶的黄酮提取物治疗使细胞抗氧化酶活力显著增强, SOD: (1.5 ± 0.6) µmol/min/mg蛋白, CAT: (0.61 ± 0.06) µmol/min/mg 蛋白, GPx: (2.6 ± 0.41) µmol/min/mg蛋白, GST: (6.0 ± 2.4) µmol/min/mg 蛋白, 显著高于缺氧对照组, 其酶活力分别为: (0.5 ± 0.52, 51 ± 0.04, 1.2 ± 0.35, 3.1 ± 1.6) µmol/min/mg蛋白。研究结果表明, 锡兰绿茶有很大的临床应用价值。饮用锡兰绿茶可能成为预防中风的有效新方法, 并能减少现代疾病对生命的威胁, 提高人类生活质量。

关键词: 中风, 中风, 中风, 缺氧, 缺氧, 缺氧, 黄酮提取物, 黄酮提取物, 黄酮提取物, ABTS, ABTS, ABTS, 邻苯三酚红, 邻苯三酚红, 邻苯三酚红, 乳酸脱氢酶, 乳酸脱氢酶, 乳酸脱氢酶, 超氧化物歧化酶, 超氧化物歧化酶, 超氧化物歧化酶, 过氧化氢酶, 过氧化氢酶, 过氧化氢酶, , ,

Abstract: We have extracted and purified flavonoids as active ingredients from Ceylon green tea (Dilmah). In this project, an in vitro hypoxic model using human brain epithelial cells (HBEC) was studied with treatment of the tea extract before inducing hypoxia. We have tested the hypothesis that flavonoids extracted from Ceylon green tea act as potential therapeutic ingredient (s) to reduce oxidative stress in hypoxic cells through its antioxidant properties and its ability to reduce cerebral cellular death. The biochemical antioxidant tests show that the Ceylon green tea has 68% ± 2.8% inhibition property of scavenging of ABTS. The inhibition of pyrogallol red bleaching by HOCl from Ceylon tea was 79% ± 4.5%. After exposing to hypoxia, the cell viability was 29% ± 2.3% in the hypoxia control group but 41% ± 4.7% for flavonoids extract treated group. In LDH assay, flavonoids extract treated group had 75% ± 3.7% reducing of LDH release. The flavonoids extract treated groups significantly increased in antioxidant enzyme activity assays: the activity level of SOD [(1.5 ± 0.6) µmol/min/mg protein], CAT [(0.61 ± 0.06) µmol/min/mg protein], GPx [(2.6 ± 0.41) µmol/min/mg protein] and GST [(6.0 ± 2.4) µmol/min/mg protein] are significantly increased as compared with hypoxic control [(0.5 ± 0.52, 0.51 ± 0.04, 1.2 ± 0.35 and 3.1 ± 1.6) µmol/min/mg protein, respectively]. The study demonstrated a great clinical potential and opened a new avenue to prevent stroke by drinking Ceylon tea.

Key words: Stroke, Stroke, Hypoxia, Hypoxia, Flavonoids extract, Flavonoids extract, ABTS, ABTS, Pyrogallol red, Pyrogallol red, Lactate dehydrogenase, Lactate dehydrogenase, Superoxide dismutase, Superoxide dismutase, Catalase, Catalase

Supporting: ^*Corresponding author. Tel.: +94-11-2802164; fax: +94-11-5524323

黄山红, Ranil De Silva^*
. 锡兰绿茶中黄酮类成分对缺氧人脑上皮细胞的治疗作用
[J]. .

Shan-Hong Huang, Ranil De Silva^*
. Therapeutic effects of flavonoids from Ceylon green tea on hypoxic human brain epithelial cells
[J]. .

参考文献

[1] Ji, X.Y.; Tan, B.K.H.; Huang, S.H.; Whiteman, M.; Zhu, Y.C.; Zhu, Y.Z. Effects of Salvia miltiorrhiza in ischemic myocardium in experimental rats. In: Novel compounds from natural products in new millenniums. Ed. Tan, B.; Bay, B.H.; Zhu, Y.Z. London: World Scientific Press. 2004, 183-195.
[2] Sun, J.; Tan, B.K.H.; Huang, S.H.; Whiteman, M.; Zhu, Y.Z. Acta Pharm. Sin. 2002, 23, 1142-1151.
[3] Sun, J.; Huang, S.H.; Zhu, Y.; Whiteman, M.; Wang, M.J.; Tan, B.K.H.; Zhu, Y.Z. Life Sci. 2005, 76, 3043-3056.
[4] Wang, Z.Q.; Porreca, F.; Cuzzocrea, S.; Galen, K.; Lightfoot, R.; Masini, E.; Muscoli, C.; Mollace, V.; Ndgenle, M.; Ischiropoulos, H.; Salvemini, D. J. Pharmacol. Exp. Ther. 2004, 309, 869-878.
[5] Korantzopoulos, P.; Siogas, K.; Galaris, D. Am. J. Kidney Dis. 2004, 43, 192.
[6] Emerit, J.; Edeas, M.; Bricaire, F. Biomed Pharm. 2004, 58, 39-46.
[7] Jellinger, K.A. J. Neural Transm Suppl. 2003, 65, 101-144.
[8] Loh, K.P.; Low, L.S.; Wong, W.H.; Chou, W.H.; Zhu, Y.Z. Neuroscience Lett. 2006, 398, 28-33.
[9] Long, L.H.; Halliwell, B. Methods Enzymol. 2001, 335, 181-90.
[10] Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice, Evans, C. Free Radic. Biol. Med. 1999, 26, 1231-1237.
[11] Goto, H.; Shimada, Y.; Akechi, Y.; Kohta, K.; Hattori, M.; Terasawa, K. Planta Med. 1996, 62, 43-69.
[12] Zhu, Y.Z.; Wang, Z.J.; Ho, P.Y.; Loke, Y.Y.; Zhu, Y.C.; Huang, S.H.; Tan, C.S.; Whiteman, M.; Lu, J.; Moore, P.K. J. Appl. Phys. 2007, 102, 261-268.
[13] Legrand, C.; Bour, J.M.; Jacob, C.; Capiaumont, J.; Martial, A.; Marc, A.; Wudtke, M.; Kretzmer, G.; Demangel, C.; Duval, D. J. Biotechnol. 1992, 25, 231-243.
[14] Decker, T.; Lohmann-Matthes, M.L.H. J Immunol Methods. 1988, 115, 61-69.
[15] Nachlas, M.M.; Margulies, S.I.; Goldberg, J.D.; Seligman, A.M. Anal. Biochem. 1960, 1, 317-326.
[16] Costa, I.E. Am. J. Physiol. 1990, 259, 25-34.
[17] Plateel, M.; Dehouck, M.P.; Tropier, G.; Cecchelli, H.; Teissier, E. J. Neurochem. 1995, 65, 2138-2145.
[18] Richardson, P.G.; Schlossman, R.L.; Weller, E.; Hideshima,
T.; Mitsiades, C.; Davies, F.; LeBlanc, R.; Catley,
L.P.; Doss, D.; Kelly, K.; McKenney, M.;
Mechlowicz, J.; Freeman, A.; Deocampo, R.; Rich, R.;
Ryoo, J.J.; Chauhan, D.; Balinski, K.; Zeldis, J.; Anderson,
K.C. Blood . 2002, 100, 3063-3067.
[19] Zimmermann, C.; Gutmann, H.; Drewe, J. Cancer
Chemoth. Pharm. 2006, 57, 599-606. [20] Rietveld, A.; Wiseman, S. J. Nutr. 2003, 133, 3285-3292.
[21] Beecher, G.R. J. Nutr. 2003, 133, 3248-3254.
[22] Lambert, J.D.; Yang, C.S. J. Nutr. 2003, 133, 3262-3267.
[23] Li, S.L.; Chan, S.S.; Lin, G.; Ling, L.; Yan, R.; Chung, H.S.; Tam, Y.K. Plant Med. 2003, 69, 445-451.
[24] Zhu, Y.Z.; Chimon, G.N.; Zhu, Y.C.; Lu, Q.; Li, B.; Hu, H.Z.; Yap, E.H.; Lee, H.S.; Wong, P. T-H. Neuroreport. 2000, 11, 1191-1194.
[25] Khaper, N.; Kaur, K.; Li, T.; Farahmand, F.; Singal, P.K. Mol. Cell. Biochem. 2003, 251, 9-15.
[26] Jackson, R.; Parish, G.; Ho, Y.S. Am. J. Physiol Lung Mol. Physiol. 1996, 271, 955-962.
[27] Kirshenbaum, L.A.; Singal, P.K. Lab. Inves. 1992, 796-803.
[28] Robin, E.D; Murphy, B.J; Theodore, J. J. Cell Physiol. 1984, 118, 287-290.
[29] Zhu, Y.Z.; Huang, S.H.; Tan, B.K.H.; Sun, J.; Whiteman, M.; Zhu, Y.C. Nat. Prod. Rep. 2004, 21, 478-489.